Milena Musilová

Publications by Year

Research Areas

Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations

Most-Cited Works

• → Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)(2016)145 cited
• → Distribution of mutations in DNMT3A gene and the suitability of mutations in R882 codon for MRD monitoring in patients with AML(2015)18 cited
• → Sensitivity, Reproducibility and Clinical Utility Of Next-Generation Sequencing (NGS) for BCR-ABL1 Kinase Domain Mutation Screening: Results From The CML Work Package Of The Iron-II (Interlaboratory RObustness Of Next-Generation Sequencing) International Study(2013)4 cited
• → BCR‐ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next‐generation sequencing(2014)3 cited
• → Extraktion von Ferroinperchlorat(1968)1 cited
• → Prospective analysis of low-levelBCR–ABL1T315I mutation in CD34 + cells of patients withde novochronic myeloid leukemia(2013)1 cited
• The prospective analysis of low-level BCR-ABL1 T315I mutation in the CD34(+) cells of de novo CML patients.(2013)
• → Pre-analytics optimization of non-invasive plasma specimens to improve KRAS mutation (KRASm) detection in patients with non-small cell lung cancer (NSCLC).(2015)
• DNMT3A gene: Distribution of the mutations and their stabilityduring treatment in patients with AML(2015)
• KRAS mutation detection details from various input plasma volumes.(2016)